Table 1 Patient characteristics
From: 68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
Characteristics | All patients (n = 37) | 68Gallium DOTATATE uptake | |
|---|---|---|---|
Positive (n = 34) | Negative (n = 3) | ||
Age, years (mean ± SD) | 59 ± 10 | 60.5 ± 9 | 43.3 ± 10 |
Sex, male (%) | 25 (68%) | 23 (68%) | 2 (67%) |
Maximum NFMA diameter (mean ± SD) | 21 ± 5.6 | 21 ± 5.5 | 16 ± 4.6 |
Previous NFMA resection, no. (%) | 19 (51%) | 18 (53%) | 1 (33%) |
Pituitary hormone deficiency, no. (%), of which: | 20 (54%) | 18 (53%) | 2 (67%) |
ACTH deficiency | 16 | 14 | 2 |
GH deficiency | 6 | 4 | 2 |
TSH deficiency | 12 | 11 | 1 |
LH/FSH deficiency | 12 | 11 | 1 |
NFMA ROI SUVmean (mean ± SD) | 5.3 ± 2.8 | 5.8 ± 2.6 | 0.9 ± 0.2 |